First Time Loading...

Arbutus Biopharma Corp
NASDAQ:ABUS

Watchlist Manager
Arbutus Biopharma Corp Logo
Arbutus Biopharma Corp
NASDAQ:ABUS
Watchlist
Price: 2.89 USD 2.85% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

144.4m
-9%
Assets
Growth Rates:
1 Year
-26%
3 Years
+5%
5 Years
-37%
7 Years
-48%
10 Years
+101%
38.4m
-2%
Liabilities
Growth Rates:
1 Year
-35%
3 Years
+9%
5 Years
+39%
7 Years
-47%
10 Years
+207%
106m
-11%
Equity
Growth Rates:
1 Year
-23%
3 Years
+4%
5 Years
-47%
7 Years
-48%
10 Years
+79%

Balance Sheet Decomposition
Arbutus Biopharma Corp

144.4m
Assets
38.4m
Liabilities
144.4m
Assets
38.4m
Liabilities
Current Assets 132m
Cash & Short-Term Investments 126m
Receivables 1.8m
Other Current Assets 4.2m
Non-Current Assets 12.4m
Long-Term Investments 6.3m
PP&E 6.1m
Current Liabilities 22.5m
Accounts Payable 3.2m
Accrued Liabilities 7.5m
Other Current Liabilities 11.8m
Non-Current Liabilities 15.9m
Other Non-Current Liabilities 15.9m

Balance Sheet
Arbutus Biopharma Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
72
167
23
54
37
32
52
109
31
26
Cash Equivalents
72
167
23
54
37
32
52
109
31
26
Short-Term Investments
40
15
107
72
88
59
71
46
116
100
Total Receivables
3
1
1
1
2
1
1
1
1
2
Accounts Receivables
2
1
0
1
1
1
1
1
1
2
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
2
1
1
2
3
2
3
4
3
4
Total Current Assets
116
184
133
129
129
94
128
161
151
132
PP&E Net
2
3
7
12
10
11
9
8
7
6
PP&E Gross
2
3
7
12
10
11
9
8
7
6
Accumulated Depreciation
11
10
11
13
7
11
15
19
22
12
Intangible Assets
0
353
99
59
44
0
0
0
0
0
Goodwill
0
163
24
24
23
0
0
0
0
0
Long-Term Investments
0
10
0
0
22
0
0
36
37
6
Other Long-Term Assets
0
0
13
13
0
0
0
0
0
0
Other Assets
0
163
24
24
23
0
0
0
0
0
Total Assets
118
N/A
712
+503%
276
-61%
237
-14%
228
-4%
106
-54%
137
+30%
205
+49%
195
-4%
144
-26%
Liabilities
Accounts Payable
2
3
3
2
3
2
3
3
4
3
Accrued Liabilities
7
6
6
9
8
5
6
8
13
7
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
11
2
1
4
1
0
0
0
17
12
Total Current Liabilities
20
11
11
15
11
8
10
11
33
22
Long-Term Debt
0
0
12
12
0
0
0
0
0
0
Deferred Income Tax
0
146
41
17
13
0
0
0
0
0
Other Liabilities
10
8
9
11
4
25
26
24
26
16
Total Liabilities
30
N/A
165
+447%
73
-56%
55
-25%
28
-49%
33
+18%
35
+7%
35
0%
59
+67%
38
-35%
Equity
Common Stock
290
834
867
926
1 006
1 036
1 135
1 287
1 319
1 350
Retained Earnings
206
267
651
738
805
970
1 046
1 134
1 204
1 277
Additional Paid In Capital
26
30
37
43
48
55
61
66
72
81
Other Equity
22
50
50
48
48
48
48
48
51
48
Total Equity
88
N/A
548
+522%
203
-63%
183
-10%
200
+10%
73
-64%
102
+40%
169
+66%
137
-19%
106
-23%
Total Liabilities & Equity
118
N/A
712
+503%
276
-61%
237
-14%
228
-4%
106
-54%
137
+30%
205
+49%
195
-4%
144
-26%
Shares Outstanding
Common Shares Outstanding
22
55
55
55
56
65
90
145
158
170
Preferred Shares Outstanding
0
0
0
1
1
1
1
0
0
0

See Also

Summary
ABUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABUS stock valuation using valuation multiples.
Wall Street Estimates
ABUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.